These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3475034)

  • 1. Effect of food on enoxacin absorption.
    Somogyi AA; Bochner F; Keal JA; Rolan PE; Smith M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):638-9. PubMed ID: 3475034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.
    Wolf R; Eberl R; Dunky A; Mertz N; Chang T; Goulet JR; Latts J
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():63-9. PubMed ID: 6389476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of food on nifedipine pharmacokinetics.
    Reitberg DP; Love SJ; Quercia GT; Zinny MA
    Clin Pharmacol Ther; 1987 Jul; 42(1):72-5. PubMed ID: 3595068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxacin concentration in human prostatic tissue after oral administration.
    Rannikko S; Malmborg AS
    J Antimicrob Chemother; 1986 Jan; 17(1):123. PubMed ID: 2419299
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary components on GI absorption of acetaminophen tablets in man.
    Jaffe JM; Colaizzi JL; Barry H
    J Pharm Sci; 1971 Nov; 60(11):1646-50. PubMed ID: 5133912
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue penetration of enoxacin.
    Wise R; Lockley R; Dent J; Webberly M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of meals on the kinetics of etretinate.
    Colburn WA; Gibson DM; Rodriguez LC; Buggé CJ; Blumenthal HP
    J Clin Pharmacol; 1985; 25(8):583-9. PubMed ID: 3841130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
    Blaser J; Stone BB; Groner MC; Zinner SH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-fat, high-protein, and high-carbohydrate meals on the pharmacokinetics of a small dose of ethanol.
    Jones AW; Jönsson KA; Kechagias S
    Br J Clin Pharmacol; 1997 Dec; 44(6):521-6. PubMed ID: 9431825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Sedman A; Rowland M
    Clin Pharmacol Ther; 1987 Jul; 42(1):33-41. PubMed ID: 3474093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days.
    Tsuei SE; Darragh AS; Brick I
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():71-4. PubMed ID: 6389477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.